Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-03, Vol.29, p.iii12-iii13 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | iii13 |
|---|---|
| container_issue | |
| container_start_page | iii12 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Firle, K.A. Szymansky, A. Witthauer, M.J. Dorado-Garcia, H. Toedling, J. Schoenbeck, K. Henssen, A.G. Hertwig, F. Eggert, A. Schulte, J.H. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy047.010 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy047_010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419325505</els_id><sourcerecordid>S0923753419325505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2550-288c3e9f52799edcb940ecdde745b703983b0e9598b7168d85b086abf5b84a273</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EEqXwAez8A27HSdzYYgVVeUjlsSgLVpZfUY0Su7LTSt3w7QQFtqxGGuncO3MQuqYwoyDKuQohBjPv7BGqegYUTtCEsoUgHCp6iiYgipLUrKzO0UXOnwCwEIWYoK-35Ezrgzeqxe6g2r3qfQw4NvhutSE6xS7a2CkfsA9br30fE96sXshQgVXGXQyx37qkdkesgsUmdtqHMeNvP7DPH0tikz-4gIPbp6hblfsh9hKdNarN7up3TtH7_WqzfCTr14en5e2amIIxIAXnpnSiYUUthLNGiwqcsdbVFdM1lIKXGpxgguuaLrjlTANfKN0wzStV1OUU0THXpJhzco3cJd-pdJQU5I9AOQqUo0A5fDcwNyPjhsMO3iWZjXfBOOsHZ7200f9DfwPBmX1I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Firle, K.A. ; Szymansky, A. ; Witthauer, M.J. ; Dorado-Garcia, H. ; Toedling, J. ; Schoenbeck, K. ; Henssen, A.G. ; Hertwig, F. ; Eggert, A. ; Schulte, J.H.</creator><creatorcontrib>Firle, K.A. ; Szymansky, A. ; Witthauer, M.J. ; Dorado-Garcia, H. ; Toedling, J. ; Schoenbeck, K. ; Henssen, A.G. ; Hertwig, F. ; Eggert, A. ; Schulte, J.H.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy047.010</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-03, Vol.29, p.iii12-iii13</ispartof><rights>2018 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2550-288c3e9f52799edcb940ecdde745b703983b0e9598b7168d85b086abf5b84a273</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Firle, K.A.</creatorcontrib><creatorcontrib>Szymansky, A.</creatorcontrib><creatorcontrib>Witthauer, M.J.</creatorcontrib><creatorcontrib>Dorado-Garcia, H.</creatorcontrib><creatorcontrib>Toedling, J.</creatorcontrib><creatorcontrib>Schoenbeck, K.</creatorcontrib><creatorcontrib>Henssen, A.G.</creatorcontrib><creatorcontrib>Hertwig, F.</creatorcontrib><creatorcontrib>Eggert, A.</creatorcontrib><creatorcontrib>Schulte, J.H.</creatorcontrib><title>Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EEqXwAez8A27HSdzYYgVVeUjlsSgLVpZfUY0Su7LTSt3w7QQFtqxGGuncO3MQuqYwoyDKuQohBjPv7BGqegYUTtCEsoUgHCp6iiYgipLUrKzO0UXOnwCwEIWYoK-35Ezrgzeqxe6g2r3qfQw4NvhutSE6xS7a2CkfsA9br30fE96sXshQgVXGXQyx37qkdkesgsUmdtqHMeNvP7DPH0tikz-4gIPbp6hblfsh9hKdNarN7up3TtH7_WqzfCTr14en5e2amIIxIAXnpnSiYUUthLNGiwqcsdbVFdM1lIKXGpxgguuaLrjlTANfKN0wzStV1OUU0THXpJhzco3cJd-pdJQU5I9AOQqUo0A5fDcwNyPjhsMO3iWZjXfBOOsHZ7200f9DfwPBmX1I</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Firle, K.A.</creator><creator>Szymansky, A.</creator><creator>Witthauer, M.J.</creator><creator>Dorado-Garcia, H.</creator><creator>Toedling, J.</creator><creator>Schoenbeck, K.</creator><creator>Henssen, A.G.</creator><creator>Hertwig, F.</creator><creator>Eggert, A.</creator><creator>Schulte, J.H.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201803</creationdate><title>Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma</title><author>Firle, K.A. ; Szymansky, A. ; Witthauer, M.J. ; Dorado-Garcia, H. ; Toedling, J. ; Schoenbeck, K. ; Henssen, A.G. ; Hertwig, F. ; Eggert, A. ; Schulte, J.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2550-288c3e9f52799edcb940ecdde745b703983b0e9598b7168d85b086abf5b84a273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Firle, K.A.</creatorcontrib><creatorcontrib>Szymansky, A.</creatorcontrib><creatorcontrib>Witthauer, M.J.</creatorcontrib><creatorcontrib>Dorado-Garcia, H.</creatorcontrib><creatorcontrib>Toedling, J.</creatorcontrib><creatorcontrib>Schoenbeck, K.</creatorcontrib><creatorcontrib>Henssen, A.G.</creatorcontrib><creatorcontrib>Hertwig, F.</creatorcontrib><creatorcontrib>Eggert, A.</creatorcontrib><creatorcontrib>Schulte, J.H.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Firle, K.A.</au><au>Szymansky, A.</au><au>Witthauer, M.J.</au><au>Dorado-Garcia, H.</au><au>Toedling, J.</au><au>Schoenbeck, K.</au><au>Henssen, A.G.</au><au>Hertwig, F.</au><au>Eggert, A.</au><au>Schulte, J.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma</atitle><jtitle>Annals of oncology</jtitle><date>2018-03</date><risdate>2018</risdate><volume>29</volume><spage>iii12</spage><epage>iii13</epage><pages>iii12-iii13</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdy047.010</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-03, Vol.29, p.iii12-iii13 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy047_010 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Preclinical evaluation of BET-bromodomain inhibitor TEN-010 as monotherapy and combination therapy in MYC-driven neuroblastoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preclinical%20evaluation%20of%20BET-bromodomain%20inhibitor%20TEN-010%20as%20monotherapy%20and%20combination%20therapy%20in%20MYC-driven%20neuroblastoma&rft.jtitle=Annals%20of%20oncology&rft.au=Firle,%20K.A.&rft.date=2018-03&rft.volume=29&rft.spage=iii12&rft.epage=iii13&rft.pages=iii12-iii13&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy047.010&rft_dat=%3Celsevier_cross%3ES0923753419325505%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419325505&rfr_iscdi=true |